Imugene selected for Poster Presentation at 2026 ASH Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Imugene Ltd has announced that its abstract regarding azer-cel has been selected for a poster presentation at the upcoming ASH Annual Meeting in Louisiana. This selection reflects the scientific merit of the trial data following a rigorous peer-review process by ASH. The poster presentation is scheduled for mid-December and aims to engage with international experts in hematology.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Imugene
- Positive amendments to Convertible Notes
- Quarterly Activities/Appendix 4C Cash Flow Report
- Further Responses in azer-cel Phase 1b Trial
- Notification of cessation of securities - IMU
- Application for quotation of securities - IMU
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene